Literature DB >> 6913407

The relationship between the transport of glucose and cations across cell membranes in isolated tissues. XI. The effect of vanadate on 45Ca-efflux and sugar transport in adipose tissue and skeletal muscle.

T Clausen, T L Andersen, M Stürup-Johansen, O Petkova.   

Abstract

(1) The effects of vanadate of hexose transport, 45Ca-exchange and (Na+, K+)-contents have been characterized in isolated adipose tissue and skeletal muscles of the rat. (2) In whole epididymal fat pads, vanadate (0.5-5.0 mM) markedly stimulated the uptake of 2-deoxy[14C]glucose as well as the efflux of 3-O-[14C]methylglucose. (3) Within the same concentration range, vanadate induced an early increase in 45Ca-washout from preloaded fat pads. The maximum increases in the fractional losses of 3-O-[14C]methylglucose and 45Ca were significantly correlated (P less than 0.001, r = 0.98). (4) In extensor digitorum longus and soleus muscles, vanadate (0.5-5.0 mM) stimulated the efflux of 3-O-[14C]methylglucose and this effect was preceded by rise in the washout of 45Ca. The maximum increases in the fractional losses pf 3-O-[14C]methylglucose and 45Ca were significantly correlated (P less than 0.005, r = 0.98). (5) In extensor digitorum longus and soleus muscles, vanadate increased K+-contents and decreased Na+ contents. (6) The stimulation of 45Ca-washout presumably reflects an increase in the cytoplasmic Ca2+ level, brought about by an inhibitory effect of vanadate on the Ca2+-sensitive ATPase of the sarcoplasmic or the endoplasmic reticulum. As demonstrated for most other insulin-like agents (Sørensen, S.S., Christensen, F. and Clausen, T. (1980) Biochim. Biophys. Acta 602, 433-445), the stimulating effect of vanadate on glucose transport appears to be associated with or mediated by a rise in the cytoplasmic Ca2+ level.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6913407     DOI: 10.1016/0005-2736(81)90332-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.

Authors:  R L Khandelwal; S Pugazhenthi
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

2.  1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle.

Authors:  J T Brozinick; T H Reynolds; D Dean; G Cartee; S W Cushman
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

3.  Influence of vanadate on glycolysis, intracellular sodium, and pH in perfused rat hearts.

Authors:  C F Geraldes; M M Castro; A D Sherry; R Ramasamy
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

4.  The effects of orthovanadate on fatty acid synthesis in isolated rat hepatocytes.

Authors:  L Agius; W J Vaartjes
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

5.  Vanadate stimulates the pumped movements of Na in skeletal muscle.

Authors:  D Erlij
Journal:  Pflugers Arch       Date:  1984-04       Impact factor: 3.657

6.  Mechanism of vanadate-induced contraction of airways smooth muscle of the guinea-pig.

Authors:  R A Nayler; M P Sparrow
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

7.  The insulin-like effect of sodium vanadate on adipocyte glucose transport is mediated at a post-insulin-receptor level.

Authors:  A Green
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

8.  The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats.

Authors:  A T Ozçelikay; C Pekiner; N Ari; Y Oztürk; A Ozüari; V M Altan
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

9.  Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus.

Authors:  N Cohen; M Halberstam; P Shlimovich; C J Chang; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.